In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from Lysimachia capillipes Hemsl
In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from Lysimachia capillipes Hemsl
复制标题
珍珠菜中毛脂苷 B 和毛脂苷 C 肠道吸收的体外和原位表征
DOI:
10.3390/molecules24071227
复制
发表时间:
2019-03
期刊:
影响因子:
4.6
通讯作者:
Gu Mancang
中科院分区:
文献类型:
--
作者:
Zhang Xu;Cheng Xiao;Wu Yali;Feng Di;Qian Yifan;Chen Liping;Yang Bo;Gu Mancang
The goal of this investigation was to determine the processes and mechanism of intestinal absorption for capilliposide B (CAPB) and capilliposide C (CAPC) from the Chinese herb, Lysimachia capillipes Hemsl. An analysis of basic parameters, such as drug concentrations, time, and behavior in different intestinal segments was analyzed by liquid chromatography-tandem mass spectrometry (LC-MS). The susceptibility of CAPB and CAPC to various inhibitors such as P-glycoprotein (P-gp) inhibitor (verapamil); multidrug resistance-associated protein 2 (MRP2) inhibitor (indomethacin); cytochrome P450 protein 3A4 (CYP3A4) inhibitor (ketoconazole); and the co-inhibitor of P-gp, MRP2 and CYP3A4 (cyclosporine A) were assessed using both caco-2 cell monolayer and single-pass intestinal perfusion (SPIP) models. As a result, CAPB and CAPC are both poorly absorbed in the intestines and exhibited segment-dependent permeability. The intestinal permeability of CAPB and CAPC were significantly increased by the co-treatment of verapamil, indomethacin. In addition, the intestinal permeability of CAPB was also enhanced by ketoconazole and cyclosporine A. It can be concluded that the intestinal absorption mechanisms of CAPB and CAPC involve processes such as facilitated passive diffusion, efflux transporters, and enzyme-mediated metabolism. Both CAPB and CAPC are suggested to be substrates of P-gp and MRP2. However, CAPB may interact with the CYP3A4 system.
登录
查看更多内容
影响因子:
5.4
作者:
Cheng Z;Zhou X;Du Z;Li W;Hu B;Tian J;Zhang L;Huang J;Jiang H
通讯作者:
Jiang H
DOI:
10.12659/msm.901183
发表时间:
2017-05-02
期刊:
Medical science monitor : international medical journal of experimental and clinical research
影响因子:
--
作者:
Shen Z;Xu L;Li J;Zhang N
通讯作者:
Zhang N
影响因子:
1.7
作者:
Lei Xin;Xiao-hui Liu;Jun Yang;Hongyi Shen;G. Ji;Xiufeng Shi;Yan Xie
通讯作者:
Lei Xin;Xiao-hui Liu;Jun Yang;Hongyi Shen;G. Ji;Xiufeng Shi;Yan Xie
影响因子:
3.9
作者:
S. Vaessen;M. V. van Lipzig;R. Pieters;C. Krul;H. Wortelboer;E. van de Steeg
通讯作者:
S. Vaessen;M. V. van Lipzig;R. Pieters;C. Krul;H. Wortelboer;E. van de Steeg
影响因子:
2.2
作者:
Huadong Sun;K. Pang
通讯作者:
Huadong Sun;K. Pang